Market Value697,308,424
Total Holdings76
File Date2026-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HUMAW / Humacyte, Inc. - Equity Warrant
FHTX / Foghorn Therapeutics Inc.
VIR / Vir Biotechnology, Inc.
XLO / Xilio Therapeutics, Inc.
IRON / Disc Medicine, Inc.
MODD / Modular Medical, Inc.
AVTX / Avalo Therapeutics, Inc.
ALKS / Alkermes plc
BTSG / BrightSpring Health Services, Inc.
CRL / Charles River Laboratories International, Inc.
FULC / Fulcrum Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
KVUE / Kenvue Inc.
MCK / McKesson Corporation
RYTM / Rhythm Pharmaceuticals, Inc. Put
VTYX / Ventyx Biosciences, Inc.
XLO / Xilio Therapeutics, Inc.
OTLK / Outlook Therapeutics, Inc. Put
CI / The Cigna Group
MODD / Modular Medical, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ABT / Abbott Laboratories
GSK / GSK plc - Depositary Receipt (Common Stock)
ENTA / Enanta Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
NMTC / NeuroOne Medical Technologies Corporation
SLP / Simulations Plus, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
EWTX / Edgewise Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
BHVN / Biohaven Ltd.
COR / Cencora, Inc.
NYXH / Nyxoah SA
CORT / Corcept Therapeutics Incorporated
CCRN / Cross Country Healthcare, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
QDEL / QuidelOrtho Corporation
OGN / Organon & Co.
SENS / Senseonics Holdings, Inc.
TFX / Teleflex Incorporated
ANIP / ANI Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc.
HAE / Haemonetics Corporation
CNTX / Context Therapeutics Inc.
RLMD / Relmada Therapeutics, Inc.
BBOT / BridgeBio Oncology Therapeutics, Inc.
ANTX / AN2 Therapeutics, Inc.
IART / Integra LifeSciences Holdings Corporation
OKUR / OnKure Therapeutics, Inc.
MNPR / Monopar Therapeutics Inc.
MMS / Maximus, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
KYMR / Kymera Therapeutics, Inc.
ELTX / Elicio Therapeutics, Inc. Put
TARA / Protara Therapeutics, Inc.
ICLR / ICON Public Limited Company
SI / Shoulder Innovations, Inc.
RAPP / Rapport Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
HYPR / Hyperfine, Inc.
WAY / Waystar Holding Corp.
SION / Sionna Therapeutics, Inc.
EMBC / Embecta Corp.
SER / Serina Therapeutics, Inc.
DRUG / Bright Minds Biosciences Inc.
REPL / Replimune Group, Inc.
IBIO / iBio, Inc.
BOLD / Boundless Bio, Inc.
AQST / Aquestive Therapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
SNY / Sanofi - Depositary Receipt (Common Stock)
EYPT / EyePoint, Inc.
TELA / TELA Bio, Inc.
LIVN / LivaNova PLC
ERAS / Erasca, Inc.
ZBH / Zimmer Biomet Holdings, Inc.
OCUL / Ocular Therapeutix, Inc.
TERN / Terns Pharmaceuticals, Inc.
ZBIO / Zenas BioPharma, Inc.
ORKA / Oruka Therapeutics, Inc.
ADGM / Adagio Medical Holdings, Inc.
AVR / Anteris Technologies Global Corp.
PRQR / ProQR Therapeutics N.V.
SVRA / Savara Inc.
OSCR / Oscar Health, Inc. Put
OVID / Ovid Therapeutics Inc.
CELC / Celcuity Inc.
NXTC / NextCure, Inc.
CNC / Centene Corporation Put
IMNM / Immunome, Inc.
CNC / Centene Corporation
ALGS / Aligos Therapeutics, Inc.